Respiratory Syncytial Virus (RSV) InfectionSymptoms, Doctors, Treatments, Advances & More
Learn About Respiratory Syncytial Virus (RSV) Infection
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Rochester General Hospital
Ann Falsey is an Infectious Disease provider practicing medicine in Rochester, New York. Dr. Falsey is rated as an Elite provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Flu, and Severe Acute Respiratory Syndrome (SARS).
Nationwide Children's Hospital
Octavio Ramilo is an Infectious Disease provider practicing medicine in Columbus, Ohio. Dr. Ramilo is rated as an Elite provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Infantile Neutropenia, and Kawasaki Disease.
Louis Bont practices practicing medicine in Utrecht, Netherlands. Mr. Bont is rated as an Elite expert by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Bronchitis, Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, and Stridor.
Summary: This is a randomized, double-blind, placebo-controlled, parallel-group trial conducted in infants and young children aged 1 to 36 months with RSV infection. A total of 498 subjects are expected to be enrolled and randomly assigned to the investigational product group or the placebo group in a 2:1 ratio; Administration will be based on the subject's weight, with a dose of 20 mg/kg three times daily...
Summary: This phase II trial tests how well remdesivir works for treatment of respiratory syncytial virus (RSV) infection of the upper respiratory tract in patients receiving cellular or bispecific antibody therapy. Cellular or bispecific antibody therapies cause suppression of the immune system, making infections more frequent and reducing the body's ability to fight the infections. RSV infections are one...